[Comparative research and follow-up study on treatment of spastic cerebral palsy with Jiaji (EX-B2) point needling].
To observe the clinical effects of Jiaji (EX-B2) needling for treatment of spastic cerebral palsy (SCP). Sixty-two SCP patients were randomized into two groups, the treatment group treated by needling, and the control group treated by sham-acupuncture, once every day for 60 times totally. The clinical effect was assessed with scoring by the modified Ashworth's scale (MAS), gross motor function measuring scale (GMFM) and WeeFIM at the end of treatment (T1), half-year (T2) and 1-year (T3) after treatment. Clinical effectiveness assessment showed that MAS scores in the treatment group reduced significantly and steadily at all the time points (P < 0.01), while in the control group, it reduced significantly at T1 (P < 0.01), but raised again at T2 and T3 to higher than that in the treatment group (P < 0.05, P < 0.01), approaching the baseline level (P > 0.05). GMFM and WeeFIM scores increased in both groups at all the three assessing time points (P < 0.01), but the increments in the treatment group were higher than those in the control group respectively (P < 0.01, P < 0.05). Jiaji (EX-B2) needling could achieve good clinical therapeutic effects on SCP.